Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia

BACKGROUND: In the ALL-BFM 95 trial for treatment of acute lymphoblastic leukemia, response to a prednisone pre-phase (prednisone response) was used for risk stratification in combination with age and white blood cell count at diagnosis, response to induction therapy and specific genetic high-risk f...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lauten, Melchior, Möricke, Anja, Beier, Rita, Zimmermann, Martin, Stanulla, Martin, Meissner, Barbara, Odenwald, Edelgard, Attarbaschi, Andishe, Niemeyer, Charlotte, Niggli, Felix, Riehm, Hansjörg, Schrappe, Martin
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2012
Teme:
Original Articles and Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396677/
https://ncbi.nlm.nih.gov/pubmed/22271901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.047613
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items